Abstract
An EBNA1-specific small molecule (JLP2) has been synthesised. As a strong binder and dimerization inhibitor of EBNA1 in vitro, JLP2 may be used as a selective luminescent agent for the imaging and inhibition of latent EBV-infected cancer cells. This journal is © the Partner Organisations 2014.
| Original language | English |
|---|---|
| Pages (from-to) | 6517-6519 |
| Journal | Chemical Communications |
| Volume | 50 |
| Issue number | 49 |
| DOIs | |
| Publication status | Published - 21 Jun 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver